eureKARE
Venture capitalSeed
Investment thesis
eureKARE focuses on synthetic biology, microbiome research, and the intersection of the two, viewing Europe's strong fundamental science base as underexploited. The firm backs scientists' commercialization efforts to create new companies, jobs, and industries. It targets cutting-edge technologies applicable to healthcare (cell therapies, microbiome-based medicine, gene therapies), agriculture, energy, and environmental sustainability, believing synthetic biology can transform industries and address pressing global challenges. eureKARE seeks to fill Europe's funding and entrepreneurship gap, supporting the growth of synthetic biology companies to build a more sustainable and equitable world.
Source: firm website, verified Aug 3, 2026.
Frequently asked questions
- What stage does eureKARE invest at?
- eureKARE invests at the Seed stage.
- What sectors does eureKARE focus on?
- eureKARE focuses on AgTech, Biotech, Climate Tech, Deep Tech, Energy, Healthtech.
Images
Similar investors
DCVC (Data Collective) is a venture capital firm that backs founders building companies which apply technology to major challenges across areas such as energy, biotech, agriculture, and machine learning.
Future Positive Capital is an investment firm backing entrepreneurs building companies that address major global challenges and shape more sustainable, preferable futures.
Innovestor is a Finnish investment manager active in venture capital, real estate, and energy storage, and also provides corporate venturing services.
Refactor is a seed-stage venture firm run as a solo capitalist by Zal, backing founders building hard tech companies that address real-world problems.
Overwater Ventures is an early-stage venture firm that partners with pre-seed and seed stage founders working on large-scale problems, offering hands-on support across launch strategy, go-to-market, fundraising, and marketing.